{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:11:31Z","timestamp":1775293891806,"version":"3.50.1"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pain Manag."],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.2217\/pmt-2018-0069","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T09:16:01Z","timestamp":1543828561000},"page":"13-16","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Recommending Buprenorphine for Pain Management"],"prefix":"10.1080","volume":"9","author":[{"given":"Aliza T","family":"Ehrlich","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Douglas Research Centre, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Darcq","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Douglas Research Centre, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507771"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.005942"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e31827ab599"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0028-x"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1601640113"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-014-0717-9"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19112"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201616"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13823"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.178"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.046"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.035"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.202"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770280111012"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S85951"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3723-08.2009"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjpain.2013.05.004"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0953-z"},{"issue":"1","key":"e_1_3_2_20_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(25)33306-9","article-title":"Buprenorphine: differential interaction with opiate receptor subtypes in vivo","volume":"223","author":"Sadee W","year":"1982","unstructured":"Sadee W , RosenbaumJS , HerzA . Buprenorphine: differential interaction with opiate receptor subtypes in vivo . J. Pharmacol. Exp. Ther.223 ( 1 ), 157 \u2013 162 ( 1982 ).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.249839"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.38"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.005"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.066613"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.05.009"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.115.099770"},{"issue":"3","key":"e_1_3_2_27_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(24)35398-4","article-title":"Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?","volume":"292","author":"Zaki PA","year":"2000","unstructured":"Zaki PA , KeithDE , Jr. , BrineGA , CarrollFI , EvansCJ . Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?J. Pharmacol. Exp. Ther.292 ( 3 ), 1127 \u2013 1134 ( 2000 ).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-080317-061522"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/laban.152"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12386"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.05.052"},{"key":"e_1_3_2_32_1","first-page":"1","article-title":"Transdermal buprenorphine for moderate chronic noncancer pain syndromes","volume":"23","author":"Pergolizzi JV","year":"2018","unstructured":"Pergolizzi JV , Jr. , ColuzziF , TaylorR , Jr . Transdermal buprenorphine for moderate chronic noncancer pain syndromes . Expert Rev. Neurother.23 , 1 \u2013 11 ( 2018 ).","journal-title":"Expert Rev. Neurother."},{"key":"e_1_3_2_33_1","unstructured":"WHO . Proposal for the inclusion of buprenorphine in the who model list of essential medicines ( 2014 ). http:\/\/www.who.int\/substance_abuse\/activities\/buprenorphine_essential_medicines.pdf ."}],"container-title":["Pain Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pmt-2018-0069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:28:03Z","timestamp":1775291283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pmt-2018-0069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.2217\/pmt-2018-0069"],"URL":"https:\/\/doi.org\/10.2217\/pmt-2018-0069","relation":{},"ISSN":["1758-1869","1758-1877"],"issn-type":[{"value":"1758-1869","type":"print"},{"value":"1758-1877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}